期刊文献+

卵巢上皮性恶性肿瘤组织RASSF1A基因启动子区甲基化的研究 被引量:8

Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors
原文传递
导出
摘要 目的探讨RASSF1A基因启动子区异常甲基化与卵巢上皮性恶性肿瘤发生、发展的关系。方法应用甲基化特异性PCR方法,检测80例卵巢上皮性恶性肿瘤组织RASSF1A基因启动子区异常甲基化。结果80例卵巢上皮性恶性肿瘤组织中,RASSF1A基因启动子区甲基化的发生率为52.5%,而相应癌旁正常组织中,RASSF1A基因启动子区均未发生甲基化(P<0.05)。浆液性癌、黏液性癌和内膜样癌中,RASSF1A基因启动子区甲基化的发生率分别为54.2%、52.4%和45.5%,差异无统计学意义。临床Ⅰ期、Ⅱ期卵巢上皮性恶性肿瘤RASSF1A基因启动子区甲基化的发生率分别为21.4%和16.7%,明显低于临床Ⅲ期(66.7%)和Ⅳ期(77.8%)。高分化组和中分化组RASSF1A基因启动子区甲基化的发生率分别为34.5%和35.0%,均低于低分化组(80.6%)。结论卵巢上皮性恶性肿瘤组织中存在RASSF1A基因启动子区的异常甲基化,甲基化与卵巢上皮性恶性肿瘤的临床分期和组织学分级有关。 Objective To investigate hypermethylation of promoter region of RASSF1A and its relationship with ovarian malignant epithelial tumors. Methods Methylation-specific PCR(MSP) was used to determine the hypermethylation of promoter region of ras association domain family 1 ( RASSF1A) gene in 80 cases of ovarian malignant epithelial tumors, Results No methylation of promoter region of RASSF1A gene was fnund in all 80 normal control tissues (0). Of 80 ovarian malignant epithelial tumors 42 were hypermethylated in promoter region of RASSF1A gene (52. 5% ). There was no statistically significant difference in the frequency of hypermethylation of RASSF1A gene among serious adenocarcinomas, mueinous adenocarcinomas and endometrioid adenocarcinomas (54. 2%, 52. 4% and 45. 5%, respectively; P 〉 0.05 ). Hypermethylation of RASSF1A gene happened more often in tumors in stage Ⅲ and Ⅳ (66.7% and 77.8% ) than that in stage Ⅰ and Ⅱ (21.4% and 16.7% ;P〈0.05). It was less frequently observed in well and moderately differentiated tumors ( 34. 5% and 35. 0% ) than in poorly differentiated tumors (80.6% ;P 〈0.05 ). Conclusion High frequency of methylation of RASSF1A promoter exists in ovarian malignant epithelial tumors As a tumor suppressor gene, its suppressor activity may be abrogated by an epigenetie mechanism. Hypermethylation of RASSF1A promoter in patients with epithelial malignant ovarian tumors is related to clinical stage and histopathological grade. It indicates poor prognosis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2005年第11期657-659,共3页 Chinese Journal of Oncology
基金 国家自然科学基金资助项目(30100104) 国家重点基础研究发展规划项目(G1998051203) 辽宁省博士启动基金资助课题(20021035)
关键词 RASSF1A基因 甲基化 卵巢肿瘤 RASSF1A gene Hypermethylation Ovarian neoplasms
  • 相关文献

参考文献11

  • 1Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev,1999, 9:158-163.
  • 2Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.Cell, 1999,99:247-257.
  • 3Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.Nat Genet, 2000,25: 315-319.
  • 4Dammann R, Yang G, Pfeifer GP. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res, 2001,61:3105-3109.
  • 5Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998,72:141-196.
  • 6Jones PA,Laird PW. Cancer epigenetics comes of age. Nat Genet, 1999,21:163-167.
  • 7Herman JG,Baylin SB. Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol, 2000,249:35-54.
  • 8Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA,1996,93:9821-9826.
  • 9Schagdarsurengin U, Gimm O, Hoang-Vu C, et al. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res,2002,62:3698-3701.
  • 10Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res, 2002,8:514-519.

同被引文献71

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部